INOVIO PHARMACEUTI earnings per share and revenue

GBM earnings per share for the last quarter are -0.75 CHF whereas the estimation was -0.97 CHF which accounts for 22.61% surprise. Company revenue for the same period amounts to 0.00 CHF despite the estimated figure of 95.62 k CHF. Estimated earnings per share for the next quarter are -0.76 CHF, and revenue is expected to reach 36.33 k CHF. Also watch annual changes over time to get a bigger picture of GBM earnings per share and revenue dynamics.